IT1393700B1 - SYNTHESIS OF 3 - {[(2R) -1-METHYLPYROLIDIN-2-IL] METHYL} -5- [2- (PHENILSULFONYL) ETYL] -1H-INDOL - Google Patents
SYNTHESIS OF 3 - {[(2R) -1-METHYLPYROLIDIN-2-IL] METHYL} -5- [2- (PHENILSULFONYL) ETYL] -1H-INDOLInfo
- Publication number
- IT1393700B1 IT1393700B1 ITMI2009A000678A ITMI20090678A IT1393700B1 IT 1393700 B1 IT1393700 B1 IT 1393700B1 IT MI2009A000678 A ITMI2009A000678 A IT MI2009A000678A IT MI20090678 A ITMI20090678 A IT MI20090678A IT 1393700 B1 IT1393700 B1 IT 1393700B1
- Authority
- IT
- Italy
- Prior art keywords
- phenilsulfonyl
- methylpyrolidin
- etyl
- indol
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000678A IT1393700B1 (en) | 2009-04-22 | 2009-04-22 | SYNTHESIS OF 3 - {[(2R) -1-METHYLPYROLIDIN-2-IL] METHYL} -5- [2- (PHENILSULFONYL) ETYL] -1H-INDOL |
PCT/EP2009/064850 WO2010121673A1 (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole |
JP2012506351A JP5663559B2 (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2R) -1-methylpyrrolidin-2-yl] methyl} -5- [2- (phenylsulfonyl) ethyl] 1H-indole |
EP09751896.3A EP2421853B1 (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole |
CN200980158923.7A CN102414198B (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole |
US12/995,390 US8426612B2 (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5[2-(phenylsulfonyl)ethyl]-1H-indole |
CA2756234A CA2756234C (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole |
ES09751896T ES2432066T3 (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3 - {[(2R) -1-methylpyrrolidin-2-yl] methyl} -5- [2- (phenylsulfonyl) ethyl] -1H-indole |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000678A IT1393700B1 (en) | 2009-04-22 | 2009-04-22 | SYNTHESIS OF 3 - {[(2R) -1-METHYLPYROLIDIN-2-IL] METHYL} -5- [2- (PHENILSULFONYL) ETYL] -1H-INDOL |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20090678A1 ITMI20090678A1 (en) | 2010-10-23 |
IT1393700B1 true IT1393700B1 (en) | 2012-05-08 |
Family
ID=41314669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2009A000678A IT1393700B1 (en) | 2009-04-22 | 2009-04-22 | SYNTHESIS OF 3 - {[(2R) -1-METHYLPYROLIDIN-2-IL] METHYL} -5- [2- (PHENILSULFONYL) ETYL] -1H-INDOL |
Country Status (8)
Country | Link |
---|---|
US (1) | US8426612B2 (en) |
EP (1) | EP2421853B1 (en) |
JP (1) | JP5663559B2 (en) |
CN (1) | CN102414198B (en) |
CA (1) | CA2756234C (en) |
ES (1) | ES2432066T3 (en) |
IT (1) | IT1393700B1 (en) |
WO (1) | WO2010121673A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102786514B (en) * | 2012-07-26 | 2014-01-29 | 武汉人福医药集团股份有限公司 | Novel preparation method of eletriptan |
CN104341397A (en) * | 2013-07-31 | 2015-02-11 | 上海威智医药科技有限公司 | Eletriptan free base with crystal forms, preparing method thereof and applications of the eletriptan free base |
CN105175397B (en) * | 2015-09-15 | 2017-10-10 | 上海现代哈森(商丘)药业有限公司 | A kind of hydrobromic acid eletriptan synthetic method |
JP2019502761A (en) * | 2016-01-21 | 2019-01-31 | ラボラトリオス レヴィ エセエレ | Method of making ((R) -3-[(-1-methylpyrrolidin-2-yl) methyl] -5- (2-phenylsulfonylethyl) -1H-indole |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2091562C (en) | 1990-10-15 | 2001-03-27 | John Eugene Macor | Indole derivatives useful in psychotherapeutics |
US5545644A (en) | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
GB9923314D0 (en) * | 1999-10-01 | 1999-12-08 | Pfizer Ltd | Acylation process |
US20030166704A1 (en) * | 2000-12-20 | 2003-09-04 | Pfizer Inc. | New process |
GB0031094D0 (en) * | 2000-12-20 | 2001-01-31 | Pfizer Ltd | New Process |
MXPA05010070A (en) | 2003-04-11 | 2005-11-23 | Pfizer | Pharmaceutical combination comprising eletriptan and sodium bicarbonate. |
GB0317229D0 (en) * | 2003-07-23 | 2003-08-27 | Pfizer Ltd | Improved process |
US6927296B2 (en) * | 2003-07-23 | 2005-08-09 | Pfizer Inc. | Process |
EP2093224A1 (en) | 2007-05-01 | 2009-08-26 | Plus Chemicals B.V. | Process for preparing eletriptan hydrobromide form beta |
US20080319205A1 (en) * | 2007-05-29 | 2008-12-25 | Roman Bednar | Process for preparing 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole |
US20100285075A1 (en) | 2007-12-17 | 2010-11-11 | Actavis Group Ptc Ehf | Novel Hemioxalate Salt of Eletriptan |
US20090299077A1 (en) * | 2008-05-22 | 2009-12-03 | Vinod Kumar Kansal | Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan |
-
2009
- 2009-04-22 IT ITMI2009A000678A patent/IT1393700B1/en active
- 2009-11-09 CN CN200980158923.7A patent/CN102414198B/en active Active
- 2009-11-09 JP JP2012506351A patent/JP5663559B2/en active Active
- 2009-11-09 US US12/995,390 patent/US8426612B2/en active Active
- 2009-11-09 CA CA2756234A patent/CA2756234C/en active Active
- 2009-11-09 ES ES09751896T patent/ES2432066T3/en active Active
- 2009-11-09 EP EP09751896.3A patent/EP2421853B1/en active Active
- 2009-11-09 WO PCT/EP2009/064850 patent/WO2010121673A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010121673A1 (en) | 2010-10-28 |
JP5663559B2 (en) | 2015-02-04 |
ES2432066T3 (en) | 2013-11-29 |
CA2756234A1 (en) | 2010-10-28 |
US8426612B2 (en) | 2013-04-23 |
CN102414198A (en) | 2012-04-11 |
ITMI20090678A1 (en) | 2010-10-23 |
US20110166364A1 (en) | 2011-07-07 |
EP2421853B1 (en) | 2013-07-24 |
CA2756234C (en) | 2017-01-03 |
EP2421853A1 (en) | 2012-02-29 |
CN102414198B (en) | 2014-11-12 |
JP2012524736A (en) | 2012-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2020008I1 (en) | PHARMACEUTICAL FORMS OF DISTROMAT TABLET | |
SMT201600075B (en) | COMPOSED OF HETEROCYCLIC DIAMMINOCARBOSSIDE | |
SMT201600267B (en) | INHIBITORS OF SYK IMIDAZOPIRAZINICI | |
SMT201600291B (en) | INHIBITORS OF HCV PROTEASIS | |
ATE486853T1 (en) | SYNTHESIS OF ACYLAMINOALKENYLENAMIDES AS SUBSTANCE P ANTAGONISTS | |
CL2014003228A1 (en) | Synthesis and intermediates of biologically active heterocyclic compounds. | |
SMT201500090B (en) | Kinase inhibitors of regulation of apoptotic signals | |
ATE537147T1 (en) | AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS | |
SMT201600031B (en) | HETEROCYCLIC COMPOUNDS OF PHENOSSIMETHYL | |
BR112012005616A2 (en) | heterocyclic antiviral compounds | |
SMT201600304B (en) | SALT CHLORIDRATE OF 4- [2 - [[5-METHYL-1- (2- NAFTALENYL] -1H-PIRAZOL-3- IL] OXY] ETYL] MORPHOLIN | |
BRPI1010852A2 (en) | heterocyclic antiviral compounds | |
BRPI1016266A2 (en) | heterocyclic antiviral compounds | |
BRPI1009873A2 (en) | improved detection of gene expression | |
DK2411009T3 (en) | Therapeutic uses of quinazoline indione derivatives | |
SMT201500268B (en) | DERIVATIVE OF 5-HYDROXYPIRYMIDIN-4-CARBOSSAMIDE | |
SMT201500156B (en) | Compounds of dihydropyrolonaphtoneone as jak inhibitors | |
IT1398296B1 (en) | ARRANGEMENT OF SENSORS | |
DK2470182T3 (en) | SYNTHESIS OF A NEUROSTIMULATING PIPERAZINE | |
IT1395539B1 (en) | FOOT OF FOOT | |
BRPI1010900A2 (en) | heterocyclic antiviral compounds | |
IT1393700B1 (en) | SYNTHESIS OF 3 - {[(2R) -1-METHYLPYROLIDIN-2-IL] METHYL} -5- [2- (PHENILSULFONYL) ETYL] -1H-INDOL | |
BRPI1006924A2 (en) | pharmaceutical compositions comprising an hcv polymerase inhibitor prodrug | |
SMT201500123B (en) | Unit dosage of apadenoson | |
DE602006006853D1 (en) | Synthesis of new dihydrobenzoxazine |